Long-Term Survival Outcomes After Liver Resection for Binodular Hepatocellular Carcinoma: A Multicenter Cohort Study

Author:

Wang Ming-Da1,Li Chao1,Li Jun1,Zhang Wan-Guang2,Jiang Wei-Qin3,Yu Jiong-Jie1,Xing Hao1,Wu Han1,Han Jun1,Li Zhen-Li1,Xu Xin-Fei1,Chen Ting-Hao4,Zhou Ya-Hao5,Gu Wei-Min6,Wang Hong7,Zeng Yong-Yi8,Zhang Yao-Ming9,Pawlik Timothy M.10,Lau Wan Yee111,Wu Meng-Chao1,Yang Jia-Mei1,Shen Feng1,Yang Tian1

Affiliation:

1. The 1st Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, People's Republic of China

2. Department of Hepatic Surgery, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, People's Republic of China

3. Cancer Biotherapy Center, First Affiliated Hospital, School of Medicine of Zhejiang University, Zhejiang, People's Republic of China

4. Department of General Surgery, Ziyang First People's Hospital, Sichuan, People's Republic of China

5. Department of Hepatobiliary Surgery, Pu'er People's Hospital, Yunnan, People's Republic of China

6. The First Department of General Surgery, the Fourth Hospital of Harbin, Heilongjiang, People's Republic of China

7. Department of General Surgery, Liuyang People's Hospital, Hunan, People's Republic of China

8. Department of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital, Fujian Medical University, Fujian, People's Republic of China

9. The Second Department of Hepatobiliary Surgery, Meizhou People's Hospital (Huangtang Hosptial), Meizhou Hospital to Sun Yat-sen University, Meizhou, People's Republic of China

10. Department of Surgery, Ohio State University, Wexner Medical Center, Columbus, Ohio, USA

11. Faculty of Medicine, the Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, N.T., Hong Kong SAR

Abstract

Abstract Background The long-term prognosis after liver resection for multinodular (≥3 nodules) hepatocellular carcinoma (HCC) is generally considered to be unfavorable. However, the role of liver resection for binodular HCC is less investigated. Subjects, Materials, and Methods From a multicenter database, consecutive patients who underwent curative-intent liver resection for binodular HCC and without macrovascular invasion between 2003 and 2015 were retrospectively reviewed. Patients’ clinical variables as well as perioperative and long-term survival outcomes were analyzed. Univariable and multivariable analyses were performed to identify the risk factors associated with overall survival (OS) and recurrence-free survival (RFS) after curative resection. Results Of 263 enrolled patients, the perioperative 30-day mortality and morbidity rates were 1.5% and 28.5%. The 1-, 3-, and 5-year OS and RFS rates were 81.5%, 52.4%, and 39.1% and 57.1%, 35.8%, and 26.6%, respectively. Multivariable Cox-regression analyses identified preoperative alpha-fetoprotein level >400 μg/L, tumor size with a sum of two nodules >8 cm, tumor size ratio of large/small nodule >1.5 (asymmetrical proportion), unilateral hemiliver distribution of two nodules, distance of ≤3 cm between two nodules, and microvascular invasion in any nodule as independent risk factors associated with decreased OS and RFS. Conclusion Liver resection was safe and feasible in patients with binodular HCC, with acceptable perioperative and long-term outcomes. Sum of two tumor sizes, size ratio and distribution, and distance between two nodules were independent risk factors associated with long-term survival outcomes after surgery. These results may guide clinicians to make individualized surgical decisions and estimate long-term prognosis for these patients.

Funder

National Natural Science Foundation of China

Shanghai Pujiang Program

Shanghai Sailing Program

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3